EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SMAD2/3-SMYD2 and developmental transcription factors cooperate with cell-cycle inhibitors to guide tissue formation

Stefania Militi, Reshma Nibhani, Martin Pook, Siim Pauklin iD

Protein & Cell · 2025

DOI: 10.1093/procel/pwae031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Protein & Cell, 2025. Verfasst von Stefania Militi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Old Road, Headington, O…. Hauptthemen laut MEDLINE: Smad2 Protein, Smad3 Protein. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pancreatic Cancer UK, Cancer Research UK, Cancer Research UK Career Development Fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tissue formation and organ homeostasis are achieved by precise coordination of proliferation and differentiation of stem cells and progenitors. While deregulation of these processes can result in degenerative disease or cancer, their molecular interplays remain unclear. Here we show that the switch of human pluripotent stem cell (hPSC) self-renewal to differentiation is associated with the induction of distinct cyclin-dependent kinase inhibitors (CDKIs). In hPSCs, Activin/Nodal/TGFβ signaling maintains CDKIs in a poised state via SMAD2/3-NANOG-OCT4-EZH2-SNON transcriptional complex. Upon gradual differentiation, CDKIs are induced by successive transcriptional complexes between SMAD2/3-SMYD2 and developmental regulators such as EOMES, thereby lengthening the G1 phase. This, in turn, induces SMAD2/3 transcriptional activity by blocking its linker phosphorylation. Such SMAD2/3-CDKI positive feedback loops drive the exit from pluripotency and stepwise cell-fate specification that could be harnessed for producing cells for therapeutic applications. Our study uncovers fundamental mechanisms of how cell-fate specification is interconnected to cell-cycle dynamics and provides insight into autonomous circuitries governing tissue self-formation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Smad2 ProteinSmad3 ProteinHumansCell DifferentiationPluripotent Stem CellsSignal TransductionOctamer Transcription Factor-3Enhancer of Zeste Homolog 2 ProteinNanog Homeobox ProteinPhosphorylation

Stichwörter der Autor:innen

EZH2SMYD2TGFβ/ACTIVIN-SMAD2/3cell cycledifferentiationepigeneticshuman pluripotent stem cells

Substanzen

Smad2 ProteinSmad3 ProteinSMAD2 protein, humanSMAD3 protein, humanOctamer Transcription Factor-3Enhancer of Zeste Homolog 2 ProteinNanog Homeobox Protein

Autor:innen und Institutionen

  • Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Old Road, Headington, Oxford OX3 7LD, United Kingdom.

ORCID-Profile: Siim Pauklin

Förderung

  • Pancreatic Cancer UK
  • Cancer Research UK
  • Cancer Research UK Career Development Fellowship
  • Federation of European Biochemical Societies longterm fellowship

Zitieren

APA

Militi, S., Nibhani, R., Pook, M., & Pauklin, S. (2025). SMAD2/3-SMYD2 and developmental transcription factors cooperate with cell-cycle inhibitors to guide tissue formation. Protein & Cell. https://doi.org/10.1093/procel/pwae031

Vancouver

Militi S, Nibhani R, Pook M, Pauklin S. SMAD2/3-SMYD2 and developmental transcription factors cooperate with cell-cycle inhibitors to guide tissue formation. Protein & Cell. 2025. doi:10.1093/procel/pwae031

BibTeX
@article{Militi2025,
  author = {Militi, Stefania and Nibhani, Reshma and Pook, Martin and Pauklin, Siim},
  title = {SMAD2/3-SMYD2 and developmental transcription factors cooperate with cell-cycle inhibitors to guide tissue formation},
  journal = {Protein & Cell},
  year = {2025},
  doi = {10.1093/procel/pwae031}
}
Kostenlos starten →